| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |